Rating Change
Maxim Group analysts initiated coverage on Nasus Pharma Ltd. (AMEX:NSRX) with a rating of Buy on October 30, 2026.
new coverageAMEX:NSRX
Maxim Group Initiates Coverage on Nasus Pharma Ltd. (NSRX) with Buy
Maxim Group analysts initiated coverage on Nasus Pharma Ltd. (AMEX:NSRX) with a rating of Buy on October 30, 2026.
At publication ·
What changed
Nasus Pharma Ltd. (AMEX:NSRX) · new coverage
- Firm
- Maxim Group
- Rating
- Buy
- Price at event
- $3.14
- Market capitalization
- $58.9M
At a glance
Key takeaways
- Maxim Group initiated Buy coverage on Nasus Pharma (NSRX) on October 30, 2026, with the stock trading at $3.14 and a market cap of $58.9M.
Market Context
Nasus Pharma Ltd. operates in the Healthcare sector. The stock currently trades at $3.14 with a market capitalization of $58.9M.
Analyst coverage from Maxim Group provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Nasus Pharma Ltd.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Nasus Pharma Ltd.
Among the 4 most recent ratings: 4 Buy, 0 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Oct 30, 2026 | Maxim Group | Buy | N/A |
| Mar 26, 2026 | Citizens | Market Outperform | N/A |
| Dec 18, 2025 | Citizens | Market Outperform | N/A |
| Sep 29, 2025 | Laidlaw & Co. | Buy | N/A |
Related Tools: Analyst Ratings Dashboard | View NSRX Stock Page
Frequently Asked Questions
What does the Buy rating mean for NSRX?
A rating of Buy from Maxim Group reflects the analyst's outlook on Nasus Pharma Ltd. (AMEX:NSRX). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the NSRX forecast page.